Home › NDC Lookup › Ingredients › Sulfur › 68605-2002-02
End-Zit Sulfur .05 g/g Lotion, Augmented, 17.57 g — NDC 68605-2002-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

End-Zit Sulfur .05 g/g Lotion, Augmented, 17.57 g — NDC 68605-2002-2 (Billing 68605-2002-02)

by ABBE Laboratories, Inc. · 17.57 g in 1 BOTTLE, GLASS

This is a package of 17.57 g of End-Zit Sulfur .05 g/g Lotion, Augmented from ABBE Laboratories, Inc., marketed since Apr 2004 and currently FDA-listed. It is this product's only package size.

NDC 68605-2002-02
🏷️ FDA NDC (as labeled) 68605-2002-2 billing pads the package segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 68605-2002-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
68605 labeler · 2002 product · 2 package
Package marketed since
Apr 20, 2004
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 6860520022 6
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68605-2002-2
Product NDC 68605-2002
11-digit billing NDC 68605200202
RxCUI 422938, 1094323
UNII 70FD1KFU70
Application # M006
SPL Set ID afed5e8e-324c-44c6-abf6-72938376a4b2
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2004-04-20
Route TOPICAL
Dosage form LOTION, AUGMENTED
Substance SULFUR
Quick answers
  • RxCUI (RxNorm): 422938
Why two NDCs? The FDA registers this code as 68605-2002-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 68605-2002-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Preparations containing sulfur class.

Drug family (ATC) Preparations containing sulfur
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is an over-the-counter topical lotion containing sulfur, marketed under FDA's monograph rules for skin-care products. Sulfur is a mineral ingredient that has been traditionally used in skin lotions to help with acne and other skin conditions. The product is applied directly to the skin and is meant for external use only. This listing represents a monograph product, meaning it follows established FDA guidelines for its category rather than undergoing individual product review.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68605-2002-02 You're viewing this Main listing 17.57 g in 1 BOTTLE, GLASS 2004-04-20 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Spot Defy 50 mg/mL 49825-0200-10 Bioelements, 1 bottle — — FDA listed —
End-Zit .05 g/mL 68605-2001-02 ABBE 14.78 ml — — FDA listed —
End-Zit .05 g/gthis 68605-2002-02 ABBE 17.57 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2004
On the market since
Apr 2004
📍
2026
Currently FDA-listed
22 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color brown / white
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 5TJD82A1ET
    A cooling crystalline substance made synthetically that is added to medicines as a fragrance, flavoring agent, and mild local irritant to produce a cooling or warming sensation on the skin or mucous membranes.
  • UNII H5RIZ3MPW4
    A chemical preservative used to prevent bacterial and fungal growth in medicines. It helps extend shelf life and maintain product safety during storage and use.
  • UNII ND2M416302
    Isopropyl alcohol is a clear liquid solvent derived from petroleum. In medicines, it dissolves active ingredients and other components, helps the product flow smoothly, and aids in sterilization during manufacturing.
  • UNII A2I8C7HI9T
    Methylparaben is a preservative derived from benzoic acid that prevents growth of bacteria, fungi, and mold in medicines. It extends the product's shelf life and maintains safety during storage.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII Z8IX2SC1OH
    Propylparaben is a chemical preservative used to prevent bacterial and fungal growth in medicines and personal care products. It helps extend shelf life and maintain product safety during storage.
  • UNII BPV390UAP0
    Sodium laureth sulfate is a mild detergent and surfactant derived from coconut oil or petroleum. It helps mix oil and water in formulations and is often used as a cleaning or foaming agent in topical products like shampoos and cleansers.
  • UNII 7SEV7J4R1U
    A powder made from a naturally occurring mineral. In medicines, talc works as a glidant and anti-caking agent, helping tablets and capsules flow smoothly during manufacturing and preventing clumping.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
  • UNII SOI2LOH54Z
    Zinc oxide is a white mineral powder used in medicines as a protective barrier agent and color additive. It helps shield skin in topical products and may also serve as a filler or opacifying ingredient.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesOTHER INGREDIENTS: Isopropyl Alcohol, Water, Zinc Oxide, Propylene Glycol, Camphor, Talc, Sodium Laureth Sulfate, Titanium Dioxide, Diazolidinyl Urea, Methylparaben, Propylparaben. May contain Iron Oxides. NDC #'s Light/Medium 68605-2001-2   Medium/Dark 68605-2002-2    Acne Control Mask 68605-2010-2

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerABBE Laboratories, Inc.
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code68605
First marketedApr 2004
Product typeHuman Otc Drug
Portfolio7 products on file

More NDCs from ABBE Laboratories, Inc. labeler code 68605

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 39 words ▾

Intended for use on blemishes only. This advanced formulation is designed to dry and aid in elimination of pimples. It is make-up quality for excellent coverage of the blemish. It is unbelievably effective, clinically tested, dermatologist approved and recommended.

⏱️ Dosage and Administration 56 words ▾

DIRECTIONS: Shake bottle well before each use. Apply directly to blemish only, using applicator. Wait a few moments until slightly dry. Pat with fingertip or clean cotton swab to blend color to skin. Make-up may be applied if desired. Should remain on skin all day. Re-apply at night to clean skin to remain on skin overnight.

⚠️ Warnings 65 words ▾

WARNINGS: • For external use only. • Using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. • Do not get into eyes. If excessive skin irritation deve lops or increases, discontinue use and consult a doctor.

🧪 Active Ingredient 7 words ▾

DRUG FACTS ACTIVE INGREDIENT ............ SULFUR 5%

🧪 Inactive Ingredients 34 words ▾

OTHER INGREDIENTS: Isopropyl Alcohol, Water, Zinc Oxide, Propylene Glycol, Camphor, Talc, Sodium Laureth Sulfate, Titanium Dioxide, Diazolidinyl Urea, Methylparaben, Propylparaben. May contain Iron Oxides. NDC #'s Light/Medium 68605-2001-2 Medium/Dark 68605-2002-2 Acne Control Mask 68605-2010-2

🎯 Purpose 4 words ▾

PURPOSE ............. ACNE TREATMENT

📄 Do Not Use 16 words ▾

NOTE: PERSONS WITH KNOWN SENSITIVITY TO SULFUR SHOULD AVOID USE OF THIS PRODUCT. KEEP FROM EYES.

📄 Keep Out of Reach of Children 7 words ▾

• Keep out of reach of children.

📄 Package Label / Principal Display Panel 219 words ▾

———PACKAGE LABEL.PRINCIPAL DISPLY PANEL——— DIRECTIONS: SHAKE BOTTLE WELL. APPLY TWICE DAILY DIRECTLY TO ACNE BREAKOUT. ALLOW TO DRY FOR 10 SECONDS. PAT TO BLEND. APPLY MAKE-UP IF DESIRED. ACTIVE INGREDIENT: SULFUR 5%. WARNINGS: AVOID IF ALLERGIC TO SULFUR AVOID CONTACT WITH EYES FOR EXTERNAL USE ONLY KEEP FROM CHILDREN Manufactured by ABBE Laboratories, Inc. Farmingdale, NY 11735 Made in the U.S.A. END-ZIT® ACNE CONTROL DRYING LOTION ABBE

0.5OZ. (14.78 g) Product Label

———PACKAGE LABEL.PRINCIPAL DISPLY PANEL——— DIRECTIONS: SHAKE BOTTLE WELL. APPLY TWICE DAILY DIRECTLY TO ACNE BREAKOUT. ALLOW TO DRY FOR 10 SECONDS. PAT TO BLEND. APPLY MAKE-UP IF DESIRED. ACTIVE INGREDIENT: SULFUR 5%. WARNINGS: AVOID IF ALLERGIC TO SULFUR AVOID CONTACT WITH EYES FOR EXTERNAL USE ONLY KEEP FROM CHILDREN Manufactured by ABBE Laboratories, Inc. Farmingdale, NY 11735 Made in the U.S.A. END-ZIT® ACNE CONTROL DRYING LOTION ABBE

0.5OZ. (14.78 g) Product Label

———PACKAGE LABEL.PRINCIPAL DISPLY PANEL——— DIRECTIONS: SHAKE BOTTLE WELL. APPLY TWICE DAILY DIRECTLY TO ACNE BREAKOUT. ALLOW TO DRY FOR 10 SECONDS. PAT TO BLEND. APPLY MAKE-UP IF DESIRED. ACTIVE INGREDIENT: SULFUR 5%. WARNINGS: AVOID IF ALLERGIC TO SULFUR AVOID CONTACT WITH EYES FOR EXTERNAL USE ONLY KEEP FROM CHILDREN Manufactured by ABBE Laboratories, Inc. Farmingdale, NY 11735 Made in the U.S.A. END-ZIT® ACNE CONTROL DRYING LOTION ABBE

2.5OZ. (70 g) Product Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for END-ZIT (this brand).

Top reported reactions

Drug Hypersensitivity162
Pain22
Dizziness20
Headache19
Malaise19
Fatigue18
Abdominal Distension16

Age at onset

Adolescent1
Adult27
Elderly21

Reporter sex

339 reports
Male · 22%
Female · 78%
Unknown · 0%

Serious outcomes

Hospitalization57
Death6
Life-threatening2
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 31 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by ABBE Laboratories, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
ABBE Laboratories, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 68605-2001-02 · ABBE 68605-2007-03 · ABBE →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.